CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients. [electronic resource]
Producer: 20190422Description: 631-640 p. digitalISSN:- 1097-0215
- Biomarkers, Tumor -- biosynthesis
- Cohort Studies
- Disease-Free Survival
- Female
- Gene Expression
- Humans
- Immunohistochemistry
- Lymph Nodes -- pathology
- Lymphatic Metastasis
- Middle Aged
- NADPH-Ferrihemoprotein Reductase -- biosynthesis
- Neoplasm Recurrence, Local -- enzymology
- Triple Negative Breast Neoplasms -- enzymology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.